HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) ...
Procedural success was achieved in 100% of evaluable patients at 6 months and 96% in 12 months “These 6- and 12-month data demonstrate a strong safety profile with highly effective and durable PVI ...
“These 6- and 12-month data demonstrate a strong safety profile with highly effective and durable PVI achieved with the nPulse Cardiac Catheter Ablation System, suggesting that this system has the ...
Abstract: This paper proposes and demonstrates an arbitrarily tunable multi-frequency pulse modulation scheme based on an active fiber loop, which effectively suppresses the interference fading effect ...
Abstract: In this digital age, there has been a surge in the transmission of digital data. This data is not secure and it can be easily intercepted and misused by an eavesdropper. To secure this data, ...
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation Pulse Biosciences, Inc. (Nasdaq: PLSE), a company ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or ...
Non-lethal deterrence helps tower owners reduce nesting/roosting disruptions, repeat dispatches, and bird-related equipment issues FLORIDA, FL, UNITED STATES ...
Escalating from last month’s internal warnings of rough vibes, OpenAI CEO Sam Altman has declared a company-wide “Code Red” to salvage his flagship product. As a result, the “Pulse” personal assistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results